Alto Neuroscience, Inc. ( ANRO) - Stock Earnings
ANRO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
ANRO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -14.2 million USD | — USD |
| 2025Q4 | -16.2 million USD | — USD |
| 2026Q1 | -26.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ANRO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.3 million USD | — USD |
| 2024 | -61.4 million USD | — USD |
| 2025 | -63.2 million USD | — USD |
| 2026 Est. | — | — |
ANRO
Price: $26.78
52 week price:
Earnings Per Share: -2.43 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 899.1 million